Cat.#: ACPP-1274
| Despition | Visfatin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1803 | Human KISS1 Protein (AC1803) | 2 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1529 | Human KCTD4 Protein (AC1529) | 2 µg | inquiry |
| ACPP-1418 | Human GAL Protein (AC1418) | 2 µg | inquiry |
| ACPP-1059 | Recombinant Human ALK Protein (Fc Tag) (AC1059) | 50 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.